Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers. | Cancers (Basel) | 2023 | 37894324 | PubTator, text mining | PubMed |
| Circulating Small Extracellular Vesicles Reflect the Severity of Myocardial Damage in STEMI Patients. | Biomolecules | 2023 | 37892152 | PubTator, text mining | PubMed |
| Comprehensive analyses identify potential biomarkers for encephalitis in HIV infection. | Sci Rep | 2023 | 37891420 | PubTator, text mining | PubMed |
| Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line. | Mol Biol Res Commun | 2023 | 37886737 | PubTator, text mining | PubMed |
| Visualization of breast cancer-related protein synthesis from the perspective of bibliometric analysis. | Eur J Med Res | 2023 | 37885035 | PubTator, text mining | PubMed |
| Breast cancer organoids and their applications for precision cancer immunotherapy. | World J Surg Oncol | 2023 | 37884976 | PubTator, text mining | PubMed |
| Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy. | J Hematol Oncol | 2023 | 37880715 | PubTator, text mining | PubMed |
| Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer. | Nat Commun | 2023 | 37872156 | PubTator, text mining | PubMed |
| Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients. | Ann Biol Clin (Paris) | 2023 | 37864443 | PubTator, text mining | PubMed |
| The strategies to cure cancer patients by eradicating cancer stem-like cells. | Mol Cancer | 2023 | 37853413 | PubTator, text mining | PubMed |
| Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality. | J Transl Med | 2023 | 37840135 | PubTator, text mining | PubMed |
| MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target. | Cancers (Basel) | 2023 | 37835473 | PubTator, text mining | PubMed |
| ROR2 homodimerization is sufficient to activate a neuronal Wnt/calcium signaling pathway. | J Biol Chem | 2023 | 37832874 | PubTator, text mining | PubMed |
| Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review). | Int J Oncol | 2023 | 37830150 | PubTator, text mining | PubMed |
| Role of Caveolae family-related proteins in the development of breast cancer. | Front Mol Biosci | 2023 | 37828916 | PubTator, text mining | PubMed |
| CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma. | J Transl Med | 2023 | 37817249 | PubTator, text mining | PubMed |
| Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy. | J Transl Med | 2023 | 37807060 | PubTator, text mining | PubMed |
| Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. | MedComm (2020) | 2023 | 37799806 | PubTator, text mining | PubMed |
| Antibody-drug conjugates: Recent advances in payloads. | Acta Pharm Sin B | 2023 | 37799390 | PubTator, text mining | PubMed |
| Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. | J Transl Med | 2023 | 37784157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=14